REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STATE STREET CORP | 2,333,108 | $26,760,749 | 0.00% |
| CAPITAL FUND MANAGEMENT S.A. | 36,572 | $419,480 | 0.00% |
| Point72 Middle East FZE | 2,085 | $23,914 | 0.00% |
| MERCER GLOBAL ADVISORS INC /ADV | 18,103 | $208 | 0.00% |
| LAZARD ASSET MANAGEMENT LLC | 77,200 | $885 | 0.00% |
| BANK OF MONTREAL /CAN/ | 5,700 | $102,372 | 0.00% |
| BANK OF MONTREAL /CAN/ | 8,510 | $152,840 | 0.00% |
| Lindbrook Capital, LLC | 274 | $3,143 | 0.00% |
| Walleye Trading LLC | 7,900 | $90,613 | 0.00% |
| Walleye Trading LLC | 500 | $5,735 | 0.00% |
| Walleye Trading LLC | 12,582 | $144,316 | 0.00% |
| LPL Financial LLC | 22,794 | $261,447 | 0.00% |
| ENVESTNET ASSET MANAGEMENT INC | 19,149 | $219,639 | 0.00% |
| Allspring Global Investments Holdings, LLC | 4,424 | $50,743 | 0.00% |
| GREAT WEST LIFE ASSURANCE CO /CAN/ | 7,525 | $86 | 0.00% |
| Citadel Advisors | 129,700 | $1,487,659 | 0.00% |
| Citadel Advisors | 115,800 | $1,328,226 | 0.00% |
| Citadel Advisors | 126,382 | $1,449,602 | 0.00% |
| Parallax Volatility Advisers, L.P. | 10,000 | $114,700 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 92,900 | $1,065,563 | 0.00% |
External links
This page lists REVANCE THERAPEUTICS INC's shareholders in Q3 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.